Investigates antiviral effects of Sonchus arvensis L. extracts on dengue virus, suggesting potential therapeutic use.
Objective: To investigate the antiviral potential of Sonchus arvensis L. extracts against dengue virus (DENV)-1 and DENV-2 in vitro , and elucidate its underlying antiviral mechanisms. Methods: The cytotoxicity of the ethanol, ethyl acetate, and n -hexane extracts of Sonchus arvensis L. was determined using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay, followed by post-treatment antiviral assays. Multiple treatment regimens were conducted to assess antiviral effects at different stages of the DENV replication cycle. qRT-PCR analysis was performed to evaluate the effects of the ethanol extract on genes associated with host innate immune and inflammatory responses. Results: The CC 50 values of the ethanol, ethyl acetate, and n -hexane extracts were 391.5 μg/mL, 104.9 μg/mL, and 409.2 μg/mL, respectively. The ethanol and ethyl acetate extracts reduced DENV- 1 and DENV-2 titers by >90% at 30-50 μg/mL, while the n -hexane extract showed comparable activity against DENV-2. The ethanol extract at 30 μg/mL demonstrated potent multi-stage antiviral activity, including direct virucidal, prophylactic, anti-adsorption, and anti-internalization effects. qRT-PCR analysis revealed no significant change in IFN-β expression but marked suppression of NF-κB , TNF-α , and IL-6 expression. Conclusions: Sonchus arvensis L. ethanol extracts demonstrate potent multi-stage antiviral activity against DENV in vitro , highlighting its ability to inhibit viral entry, reduce viral replication, and attenuate excessive inflammatory responses.
No takes yet. Share an insight, caveat, or question.
Zulkefle et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: